Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ELSEN PHARMA from Yvoir, company number BE0446359356, closed financial year 2025 with a result of € -75,149 after tax. For that financial year ELSEN PHARMA recorded a gross margin of € 5,735 and equity of € 499,552. Compared with financial year 2024, the result moved from € 525,009 to € -75,149. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 499,552
▼ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -75,149
▼ still € 525,009 profit in 2024
Profit after tax over the fiscal year.
€ 78,533
▼ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 364,857.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 350
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 138,498
▲ 131% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 72,890
▼ 34% vs 2024
€ 23,592 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 6,326
▼ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 605
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 70,050 | € 81,414 | € 842,841 | € 5,735 | ▼ 99% |
| Profit after taxes | € -21,384 | € 3,947 | € 525,009 | € -75,149 | ▼ € 600,159 |
| Equity | € 597,038 | € 479,110 | € 573,834 | € 499,552 | ▼ 13% |
| Total debts | € 315,086 | € 288,022 | € 606,583 | € 573,228 | ▼ 5% |
| Cash | € 17,547 | € 30,022 | € 87,019 | € 78,533 | ▼ 10% |
| Land & buildings | € 629,471 | € 605,737 | € 987,232 | € 956,252 | ▼ 3% |
| Retained profit | € 9,942 | € -90,526 | € 436,811 | € 364,857 | ▼ 16% |
| Dividend | € 134,756 | € 121,875 | € 0 | € 0 | |
| Bank debt | € 169,844 | € 150,932 | € 110,764 | € 72,890 | ▼ 34% |
| Balance sheet total | € 933,762 | € 786,971 | € 1,406,833 | € 1,291,888 | ▼ 8% |
Key figures of ELSEN PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ELSEN PHARMA?
What happened at ELSEN PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 75,149 (▼ € 600,159 vs 2024). filed late Source: NBB ↗
- Isabelle Elsen became a director. NBB
- Ghislaine Prève Catherine became a director. NBB
- Christian ELSEN became a director. NBB
- New establishment in Yvoir. KBO
- Start of the company according to the CBE. KBO
In short
From € 21,384 loss in 2022 to € 75,149 loss in 2025.
Paid € 10,251 in corporate taxes since 2022.
Best year ever: 2024, with € 525,009 profit.
Paid out € 256,631 in dividends to the owners in total.
Management
Behind ELSEN PHARMA are Ghislaine Prève Catherine, Christian ELSEN and Isabelle Elsen.
Directors
According to the 2025 annual accounts
Ghislaine Prève Catherine
Director
since 2004
Christian ELSEN
Managing director
since 2004
Isabelle Elsen
Director
since 2005
Establishments
Establishment units
Physical locations of this company
Avenue François-de-Lhoneux 9
5530 Yvoir
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
INFOMANIAK-AS, CH
DNS
OVH DNS
Domain
Domain
pharmacie-dejardin.com
Registered
2019-10-18
Registrar
OVH, SAS
Expires
2026-10-18
Website info
Features
Security
Network
Details
- Company number
- 0446.359.356
- VAT number
- BE 0446.359.356
- Registered office
- Avenue François-de-Lhoneux 9, 5530 Yvoir
- Names & denominations
- ELSEN PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 January 1992
- Peppol
- Active · Active since 11 Dec 2025
- Contact
- pharmacie-dejardin.com +32-82711470
- Activities · NACE
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Detailhandel in farmaceutische producten
Apothekers